USE OF SULFATED OLIGOSACCHARIDES IN MANUFACTURE OF MEDICAMENT FOR TREATING PATIENTS WITH HEPATOCELLULAR CARCINOMA AFTER SURGICAL RESECTION

A use of sulfated oligosaccharides in the manufacture of a medicament for reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma (HCC) patientwith microvascular invasion after curative liver resection, while excluding HCC patients with no vas...

Full description

Saved in:
Bibliographic Details
Main Authors LAI KUAN-LANG, CHANG STANLEY
Format Patent
LanguageChinese
English
Published 25.10.2019
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A use of sulfated oligosaccharides in the manufacture of a medicament for reducing intrahepatic tumor recurrence and increasing disease-free survival period in a hepatocellular carcinoma (HCC) patientwith microvascular invasion after curative liver resection, while excluding HCC patients with no vascular invasion and HCC patients with macrovascular invasion is provided. 本发明系关于一种硫化寡糖在制备供根治性肝脏切除后的微小血管侵犯型肝细胞癌(HCC)患者用于减低肝内肿瘤复发及延长无疾病存活期的一药物的用途，且排除无血管侵犯型肝细胞癌患者及大血管侵犯型肝细胞癌患者。
Bibliography:Application Number: CN201880014397